drugset / Trial / NCT05902078
Eldecalcitol and Calcitriol in Postmenopausal Women With Low Bone Mineral Density or Mild Osteoporosis
Phase 4
Unknown
300 enrolled
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Chugai Pharma China · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
To investigate the efficacy and safety of eldecalcitol in postmenopausal women with low bone mineral density (BMD) or mild osteoporosis through a randomized, open-label, parallel controlled trial with calcitriol as the control.
Timeline
- Start
- 2023-09-27
- Primary completion
- 2025-06
- Completion
- 2025-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Calcitriol | Small molecule | 0.5 ug | Oral |
| Subject | Eldecalcitol | Small molecule | 0.75 ug | Oral |